GAI
MRVI icon

General American Investors’s Maravai LifeSciences MRVI Stock Holding History

General American Investors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Hold
1,716,193
– – 0.63% 44
2026
Q1 		$4.86M Buy
1,716,193
+130,877
+8% +$444K 0.32% 57
2025
Q4 		$5.15M Buy
1,585,316
+1,448,907
+1,062% +$4.88M 0.29% 64
2025
Q3 		$391K Buy
+136,409
New +$348K 0.02% 74

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

General American Investors's MRVI Position: Q2 2026 in Review

General American Investors held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 1,716,193 shares worth $10.7M. The position accounts for 0.63% of the portfolio, ranked #44.

General American Investors first reported a position in MRVI in Q3 2025 and has held it in 4 quarters since. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • General American Investors held 1,716,193 shares of Maravai LifeSciences worth $10.7M as of Q2 2026.
  • General American Investors left its Maravai LifeSciences share count unchanged in Q2 2026.
  • Maravai LifeSciences made up 0.63% of General American Investors's portfolio in Q2 2026, its #44 holding.
  • General American Investors first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 4 quarters since.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on General American Investors's 13F filing for Q2 2026, filed 31 Jul 2026.